CG ONCOLOGY INC(NASDAQ:CGON) stock News

CGON Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Chartmill - Mentions: MEDP REPL PGEN HTOO ...

Which stocks are moving before the opening bell on Tuesday?

2 days ago - By: The Motley Fool

Cg Oncology (CGON) Q2 Loss Widens 93%

2 days ago - By: CG Oncology Inc.

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

2 days ago - By: CG Oncology Inc.

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

4 days ago - By: Zacks Investment Research - Mentions: ABUS

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

10 days ago - By: Yahoo Finance

CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial

12 days ago - By: CG Oncology Inc. - Mentions: ANIP

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

12 days ago - By: CG Oncology Inc.

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

19 days ago - By: Benzinga - Mentions: ACHC REPL MEDP IOVA ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

25 days ago - By: Benzinga

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock

a month ago - By: Yahoo Finance - Mentions: LEGN MS

H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target

a month ago - By: Yahoo Finance - Mentions: MS OKE

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating

2 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

2 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

3 months ago - By: Zacks Investment Research - Mentions: JNJ MRK IBRX

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success

3 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

3 months ago - By: Zacks Investment Research - Mentions: SLAB LSTR UAA

Company News for May 14, 2025

3 months ago - By: Zacks Investment Research - Mentions: ATRA

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates

3 months ago - By: CG Oncology Inc.

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: CG Oncology Inc.

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: Zacks Investment Research - Mentions: YMAB

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: STOK

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

3 months ago - By: CG Oncology Inc.

CG ONCOLOGY INC (CGON) Stock News

CGON Latest News, Press Relases and Analysis

Which stocks are moving before the opening bell on Tuesday?

Cg Oncology (CGON) Q2 Loss Widens 93%

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock

H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Company News for May 14, 2025

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award